| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
ESTA
Establishment Labs Holdings
|
Nov 06, 2025 | BUY |
Strong Buy
-1.6% avg upside
12 analysts
|
$75.00
11.51% Downside
|
+27.2% |
|
BLCO
Bausch + Lomb Corporation
|
Dec 12, 2024 | BUY |
Buy
+30.8% avg upside
19 analysts
|
$25.00
68.21% Upside
|
-18.5% |
|
TARS
Tarsus Pharmaceuticals
|
Mar 06, 2024 | BUY |
Strong Buy
+20.6% avg upside
16 analysts
|
$44.00
30.30% Downside
|
+101.0% |
|
STAA
Staar Surgical
|
Jan 09, 2023 | BUY |
Hold
+14.2% avg upside
16 analysts
|
$90.00
209.02% Upside
|
-64.7% |
|
COO
Cooper Co
|
Oct 11, 2022 | HOLD |
Buy
+102.3% avg upside
21 analysts
|
$295.00
347.56% Upside
|
+66.6% |
|
AXGN
AxoGen
|
Jul 18, 2022 | BUY |
Strong Buy
-25.7% avg upside
21 analysts
|
$25.00
44.18% Downside
|
+2.4% |
|
CH:ALC
Alcon
|
May 11, 2022 | BUY |
Buy
+33.9% avg upside
35 analysts
|
$77.66
46.91% Upside
|
· |
|
TELA
TELA Bio
|
Mar 21, 2022 | BUY |
Strong Buy
+1023.6% avg upside
8 analysts
|
$20.00
2396.96% Upside
|
-58.1% |
|
LNTH
Lantheus
|
Mar 14, 2022 | BUY |
Strong Buy
-27.9% avg upside
20 analysts
|
$60.00
42.21% Downside
|
+20.0% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.